Tumor Metabolism-Rewriting Nanomedicines for Cancer Immunotherapy
ACS Central Science · 25.10.2023 · 9 (10) · 1864-1893
DOI: 10.1021/acscentsci.3c00702 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ACS Central Science, online erschienen am 22.09.2023. Verfasst von Xiao Dong und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, School of Medicine, Shanghai University, Shanghai 200444, China. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 201 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education - Singapore, Science and Technology Commission of Shanghai Municipality, Shanghai Municipal Health Commission.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Pharmacy, School of Medicine, Shanghai University, Shanghai 200444, China.
- School of Bioengineering, Dalian University of Technology, Dalian 116024, China.
- Hongqiao International Institute of Medicine, Tongren Hospital and State Key Laboratory of Systems Medicine for Cancer, Department of Pharmacology and Chemical Biology, Shanghai Jiao Tong University School of Medicine,…
- Department of Chemistry, National University of Singapore, Singapore 117543, Singapore.
- Institute of Interdisciplinary Integrative Biomedical Research, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203 China.
- Key Laboratory of Basic Pharmacology of Ministry of Education & Joint International Research Laboratory of Ethnomedicine of Ministry of Education, Zunyi Medical University, Zunyi 563003, China.
ORCID-Profile: Shao Q Yao, Chao Fang
Förderung
- Ministry of Education - Singapore
- Science and Technology Commission of Shanghai Municipality
- Shanghai Municipal Health Commission
- National Natural Science Foundation of China
Zitieren
APA
Dong, X., Xia, S., Du, S., Zhu, M. H., Lai, X., Yao, S. Q., Chen, H. Z., & Fang, C. (2023). Tumor Metabolism-Rewriting Nanomedicines for Cancer Immunotherapy. ACS Central Science, 9(10), 1864-1893. https://doi.org/10.1021/acscentsci.3c00702
Vancouver
Dong X, Xia S, Du S, Zhu MH, Lai X, Yao SQ, et al. Tumor Metabolism-Rewriting Nanomedicines for Cancer Immunotherapy. ACS Central Science. 2023;9(10):1864-1893. doi:10.1021/acscentsci.3c00702
BibTeX
@article{Dong2023,
author = {Dong, Xiao and Xia, Shu and Du, Shubo and Zhu, Mao-Hua and Lai, Xing and Yao, Shao Q and Chen, Hong-Zhuan and Fang, Chao},
title = {Tumor Metabolism-Rewriting Nanomedicines for Cancer Immunotherapy},
journal = {ACS Central Science},
year = {2023},
volume = {9},
number = {10},
pages = {1864--1893},
doi = {10.1021/acscentsci.3c00702}
}
EUVIMED